Health costs of the UK-US trade deal on pharmaceuticals

<b>Samuel Cross, Karl Claxton, and Andrew Hill</b> argue that diversion of billions of NHS funding to pay more for new drugs under the UK-US trade deal will harm public health and result in thousands of excess deaths

Authors

Institutions

Publication Details

Journal
BMJ
Published
2026-07-01
DOI
https://doi.org/10.1136/bmj-2026-340588
Citations
1
Primary Topic
Global Public Health Policies and Epidemiology
Type
article
Field-Weighted Citation Impact
24.60
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Health costs of the UK-US trade deal on pharmaceuticals

K Claxton, Samuel H. Cross, Andrew Hill
1 citations
BMJ
Global Public Health Policies and Epidemiology
24.60
article

Health costs of the UK-US trade deal on pharmaceuticals

K Claxton, Samuel H. Cross, Andrew Hill
article en
1 citations

Abstract

<b>Samuel Cross, Karl Claxton, and Andrew Hill</b> argue that diversion of billions of NHS funding to pay more for new drugs under the UK-US trade deal will harm public health and result in thousands of excess deaths

BMJVol. 394
University of Liverpool (GB), Christchurch Hospital (NZ), University of York (GB)
Partnerships for the goals
Openalex Percentile: Top 1%
Global Public Health Policies and Epidemiology
24.60
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Health costs of the UK-US trade deal on pharmaceuticals — K Claxton, Samuel H. Cross, et al. · BMJ (2026) | TGRS Research Map | TGRS